Newsletter | May 14, 2020

05.14.20 -- Boosting Support To Sites During The Pandemic

 
How To Boost Support To Sites With Digital Clinical Technologies During The COVID-19 Crisis And Beyond
 

Many of the digital solutions previously viewed as “nice to have” for clinical trial optimization are now proving to be vital to support sites. Here are five areas where sponsors are deploying digital clinical technologies to boost support to sites and enable innovative drug development to continue — not only during the COVID-19 crisis but well into the future.

Staying Connected In Crisis: Strong Site Communication Channels Stand Up To Pressure
 

Clinical research is in an unprecedented state of flux due to COVID19, and investigators need to trust that the information they are receiving is reliable and authoritative. Strong communication channels keep sites updated and engaged even when study activities are limited; so when it’s time to start up again, they can hit the ground running.

Five Frequently Asked Questions (And Answers) About eConsent During The COVID-19 Crisis
 

Sponsors and sites are looking for ways to modify protocols, keep patients engaged, and apply digital technologies in new and faster ways as face-to-face interactions are limited. Here are some of the most frequently asked questions about adding remote consent capabilities to ongoing and new COVID-19 trials, along with responses that be of value to your organization at this time.

Five Easy Investigator Payment Fixes To Improve Site Relations
 

Investigator payments have long been a challenge for both sponsors and sites because the process is often complex, fragmented, lacking in transparency, and without standardization. This article reviews five common issues that delay site payments and offers recommendations to resolve these issues, improving payment efficiencies, and, ultimately, site satisfaction.